BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6347002)

  • 1. Effect of adjuvants on orally administered antigens.
    Genco RJ; Linzer R; Evans RT
    Ann N Y Acad Sci; 1983 Jun; 409():650-68. PubMed ID: 6347002
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vaccination strategies for the control of mucosal infection.
    Husband AJ
    Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotype-specific immunoregulation: T contrasuppressor cells protect IgA responses in oral tolerance.
    Kitamura K; Suzuki I; Kiyono H; Kurita T; Berry AK; Green DR; McGhee JR
    Adv Exp Med Biol; 1987; 216A():143-8. PubMed ID: 2961203
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Peyer's patches to tonsils. Specific stimulation with ribosomal immunotherapy.
    Béné MC; Faure GC
    Drugs; 1997; 54 Suppl 1():24-8. PubMed ID: 9378075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of immunoglobulin A production in Peyer's patches by oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (Shosaiko-to).
    Tauchi Y; Yamada A; Kawakita T; Saito Y; Suzuki A; Yoshikai Y; Nomoto K
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):251-72. PubMed ID: 8349952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The induction of tolerance to a soluble protein antigen by oral administration.
    Thomas HC; Parrott MV
    Immunology; 1974 Oct; 27(4):631-9. PubMed ID: 4474140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of systemic and mucosal immune response following nasal administration of liposomes.
    Aramaki Y; Fujii Y; Yachi K; Kikuchi H; Tsuchiya S
    Vaccine; 1994 Oct; 12(13):1241-5. PubMed ID: 7839731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response.
    Chen KS; Strober W
    Eur J Immunol; 1990 Feb; 20(2):433-6. PubMed ID: 2311649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioadhesive capacity and immunoadjuvant properties of thiamine-coated nanoparticles.
    Salman HH; Gamazo C; Agüeros M; Irache JM
    Vaccine; 2007 Nov; 25(48):8123-32. PubMed ID: 18029067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of a bacterial immunomodulator enhances murine intestinal lamina propria and Peyer's patch lymphocyte traffic to the lung: possible implications for infectious disease prophylaxis and therapy.
    Ruedl C; Albini B; Böck G; Wick G; Wolf H
    Int Immunol; 1993 Jan; 5(1):29-36. PubMed ID: 7680225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral antigen in T-cell receptor transgenic mice.
    Hurst SD; Lee HO; Smith MP; Rosenberg JG; Barrett TA
    Ann N Y Acad Sci; 1996 Feb; 778():163-73. PubMed ID: 8610970
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral tolerance.
    Garside P; Mowat AM
    Semin Immunol; 2001 Jun; 13(3):177-85. PubMed ID: 11394960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral tolerance and accessory-cell function of Peyer's patches.
    Tomasi TB; Barr WG; Challacombe SJ; Curran G
    Ann N Y Acad Sci; 1983 Jun; 409():145-63. PubMed ID: 6191610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral tolerance and its role in clinical disease.
    Spiekermann GM; Walker WA
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):237-55. PubMed ID: 11345170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.